Search

Dr Reddy's Lab announces strategic deal with Gland Pharma in US market

The portfolio is a mix of filed ANDAs pending approval by the US Food and Drug Administration (USFDA) and ANDAs that will be filed imminently. The portfolio comprised of generic injectables administered in hospitals and clinics in the US.

Oct 27, 2016 13:02 IST
facebook IconTwitter IconWhatsapp Icon

Pharmaceutical giant Dr Reddy's Laboratories Ltd on 26 October 2016 announced that it entered into a strategic collaboration with Gland Pharma. The companies entered into the deal to market and distribute a diverse portfolio of eight injectable Abbreviated New Drug Applications (ANDAs).

The portfolio is a mix of filed ANDAs pending approval by the US Food and Drug Administration (USFDA) and ANDAs that will be filed imminently. The portfolio comprised of generic injectables administered in hospitals and clinics in the US.

CA eBook

About Dr Reddy's Laboratories

Dr Reddy's Laboratories is an Indian multinational pharmaceutical company based in Hyderabad, Telangana.

The company was founded by Anji Reddy, who previously worked in the mentor institute, Indian Drugs and Pharmaceuticals Limited.

Dr Reddy's manufactures and markets a wide range of pharmaceuticals in India and overseas.

The company has over 190 medications, 60 active pharmaceutical ingredients (APIs) for drug manufacture, diagnostic kits, critical care and biotechnology products.

 

Download our Current Affairs & GK app For exam preparation

डाउनलोड करें करेंट अफेयर्स ऐप एग्जाम की तैयारी के लिए

AndroidIOS